Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Randomized, Double Blind, Parallel Groups, Placebo Controlled Clinical Study to Evaluate the Efficacy and Safety of the Lactobacillus Vaccine Gynevac, in the Treatment of Bacterial Vaginosis

NCT02173184 is registered in ClinicalTrials.gov with Amvac Kft. as lead sponsor.

NCT NCT02173184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02173184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Randomized, Double Blind, Parallel Groups, Placebo Controlled Clinical Study to Evaluate the Efficacy and Safety of the Lactobacillus Vaccine Gynevac, in the Treatment of Bacterial Vaginosis
Lead sponsor
Amvac Kft.
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2014
Completion date
July 31, 2015
Enrollment
240 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial vaginosis